Indomethacin and pancreatic stent for pancreatitis prophylaxis after ERCP

This Medudy course is a video tutorial for physicians on the topic of "Indomethacin and pancreatic stent for pancreatitis prophylaxis after ERCP". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.

To prevent pancreatitis after endoscopic retrograde cholangiopancreaticography (ERCP), the combination of rectally administered indomethacin and the placement of a prophylactic pancreatic stent is recommended for high-risk patients. However, stent placement is a technically complex, costly and potentially risky procedure.
Previous research suggested that the use of indomethacin could avoid stent placement and thus reduce the above risk.

Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.

At the end of this course you will know
- the clinical background and relevance of the research question under investigation
- the study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations

Further courses